Lieberman's Massive Connections To Big Pharma

 

ED NOTE: FYI - Psychiatrist Jeffrey Alan Lieberman, MD, is the current head of the American Psychiatric Association (APA). Read this introduction then scroll down to the "Read more ... " for a revealing commentary on the house of corruption that psychiatry and Big Pharma share.

'Oh, so no conflicts of interest there, then.  Big Pharma owns the psychiatric and medical industries? No, no, that's just a silly rumour, a ridiculous conspiracy theory. We should find a pill for that. Oh, we already have? Perfect. Jeffreeeeeey!'--David Icke

'In 2011, his disclosure at Medscape of relevant financial relationships says he served on the advisory board of Bioline, GlaxoSmithKline, Intra-Cellular Therapies, Eli Lilly, Pierre Fabre, and Psychogenics, and that he received research grants from Allon Therapeutics, GlaxoSmithKline, Ortho-McNeil-Janssen, Merck, Novartis, Pfizer, Sepracor, and Targacept.


He also disclosed in 2013, as a member of the psychiatry editorial board at Medscape, that he received research grants from Allon, Novartis, Sepracor, and Targacept; and he served on the advisory boards at Bioline, Intra-Cellular Therapies, Pierre Fabre and Psychogenics. 

In additional disclosures at Medscape in 2013, he received research grants from Allon, GlaxoSmithKline, Eli Lilly, Merck, Novartis, Pfizer, Psychogenics, Hoffmann-La Roche, Sepracor, and Targacept, and he served on the advisory board of Alkermes, Bioline, Intra-Cellular Therapies, Pierre Fabre, and Psychogenics.’'


INFORMATION SOURCE

APA President urges cooperation with big pharma regardless of unethical advertising, bribery and suppression of scientific data

'In a recent message to subscribers, American Psychiatric Association President Jeffrey Lieberman urged members to support big pharma.

He did this while openly admitting that the pharmaceutical industry makes a practice of advertising unethically, paying off doctors, and suppressing critical scientific data as to the dangers of their drugs. With calm and poise, President Lieberman reminded APA members that we need big pharma and they need us. In fact, he suggests we'd be lost without them.'

Read more...